Erica C Kaye1, Courtney A Gushue2,3, Samantha DeMarsh4, Jonathan Jerkins2,3, April Sykes1, Zhaohua Lu1, Jennifer M Snaman5,6, Lindsay Blazin1, Liza-Marie Johnson1, Deena R Levine1, R Ray Morrison1, Justin N Baker1. 1. Department of Oncology, Division of Quality of Life and Palliative Care, St. Jude Children's Research Hospital, Memphis, Tennessee. 2. Department of Pediatrics, Le Bonheur Children's Hospital, Memphis, Tennessee. 3. Department of Pediatrics, University of Tennessee Health Science Center, Memphis, Tennessee. 4. Ohio University Heritage College of Osteopathic Medicine, Cleveland, Ohio. 5. Department of Psychosocial Oncology and Palliative Care, Division of Pediatric Palliative Care, Dana-Farber Cancer Institute, Boston, Massachusetts. 6. Department of Psychosocial Oncology and Palliative Care, Division of Pediatric Palliative Care, Boston Children's Hospital, Boston, Massachusetts.
Abstract
BACKGROUND: The field of pediatric palliative oncology is newly emerging. Little is known about the characteristics and illness experiences of children with cancer who receive palliative care (PC). METHODS: A retrospective cohort study of 321 pediatric oncology patients enrolled in PC who died between 2011 and 2015 was conducted at a large academic pediatric cancer center using a comprehensive standardized data extraction tool. RESULTS: The majority of pediatric palliative oncology patients received experimental therapy (79.4%), with 40.5% enrolled on a phase I trial. Approximately one-third received cancer-directed therapy during the last month of life (35.5%). More than half had at least one intensive care unit hospitalization (51.4%), with this subset demonstrating considerable exposure to mechanical ventilation (44.8%), invasive procedures (20%), and cardiopulmonary resuscitation (12.1%). Of the 122 patients who died in the hospital, 44.3% died in the intensive care unit. Patients with late PC involvement occurring less than 30 days before death had higher odds of dying in the intensive care unit over the home/hospice setting compared to those with earlier PC involvement (OR: 4.7, 95% CI: 2.47-8.97, P < 0.0001). CONCLUSIONS: Children with cancer who receive PC experience a high burden of intensive treatments and often die in inpatient intensive care settings. Delayed PC involvement is associated with increased odds of dying in the intensive care unit. Prospective investigation of early PC involvement in children with high-risk cancer is needed to better understand potential impacts on cost-effectiveness, quality of life, and delivery of goal concordant care.
BACKGROUND: The field of pediatric palliative oncology is newly emerging. Little is known about the characteristics and illness experiences of children with cancer who receive palliative care (PC). METHODS: A retrospective cohort study of 321 pediatric oncology patients enrolled in PC who died between 2011 and 2015 was conducted at a large academic pediatric cancer center using a comprehensive standardized data extraction tool. RESULTS: The majority of pediatric palliative oncology patients received experimental therapy (79.4%), with 40.5% enrolled on a phase I trial. Approximately one-third received cancer-directed therapy during the last month of life (35.5%). More than half had at least one intensive care unit hospitalization (51.4%), with this subset demonstrating considerable exposure to mechanical ventilation (44.8%), invasive procedures (20%), and cardiopulmonary resuscitation (12.1%). Of the 122 patients who died in the hospital, 44.3% died in the intensive care unit. Patients with late PC involvement occurring less than 30 days before death had higher odds of dying in the intensive care unit over the home/hospice setting compared to those with earlier PC involvement (OR: 4.7, 95% CI: 2.47-8.97, P < 0.0001). CONCLUSIONS:Children with cancer who receive PC experience a high burden of intensive treatments and often die in inpatient intensive care settings. Delayed PC involvement is associated with increased odds of dying in the intensive care unit. Prospective investigation of early PC involvement in children with high-risk cancer is needed to better understand potential impacts on cost-effectiveness, quality of life, and delivery of goal concordant care.
Authors: Chris Feudtner; Tammy I Kang; Kari R Hexem; Stefan J Friedrichsdorf; Kaci Osenga; Harold Siden; Sarah E Friebert; Ross M Hays; Veronica Dussel; Joanne Wolfe Journal: Pediatrics Date: 2011-05-09 Impact factor: 7.124
Authors: Julia Berendt; Stephanie Stiel; Steffen T Simon; Andrea Schmitz; Birgitt van Oorschot; Peter Stachura; Christoph Ostgathe Journal: Oncologist Date: 2016-07-20
Authors: Thomas J Smith; Sarah Temin; Erin R Alesi; Amy P Abernethy; Tracy A Balboni; Ethan M Basch; Betty R Ferrell; Matt Loscalzo; Diane E Meier; Judith A Paice; Jeffrey M Peppercorn; Mark Somerfield; Ellen Stovall; Jamie H Von Roenn Journal: J Clin Oncol Date: 2012-02-06 Impact factor: 44.544
Authors: Katie M Moynihan; Jennifer M Snaman; Erica C Kaye; Wynne E Morrison; Aaron G DeWitt; Loren D Sacks; Jess L Thompson; Jennifer M Hwang; Valerie Bailey; Deborah A Lafond; Joanne Wolfe; Elizabeth D Blume Journal: Pediatrics Date: 2019-08 Impact factor: 7.124
Authors: Erica C Kaye; Jonathan Jerkins; Courtney A Gushue; Samantha DeMarsh; April Sykes; Zhaohua Lu; Jennifer M Snaman; Lindsay Blazin; Liza-Marie Johnson; Deena R Levine; R Ray Morrison; Justin N Baker Journal: J Pain Symptom Manage Date: 2018-02-08 Impact factor: 3.612
Authors: Lori Wiener; Sima Bedoya; Haven Battles; Leonard Sender; Keri Zabokrtsky; Kristine A Donovan; Lora M A Thompson; Barbara B Lubrano di Ciccone; Margarita Bobonis Babilonia; Karen Fasciano; Paige Malinowski; Maureen Lyon; Jessica Thompkins; Corey Heath; Denise Velazquez; Karen Long-Traynor; Abigail Fry; Maryland Pao Journal: Palliat Support Care Date: 2022-08
Authors: Ursula M Sansom-Daly; Lori Wiener; Anne-Sophie Darlington; Hanneke Poort; Abby R Rosenberg; Meaghann S Weaver; Fiona Schulte; Antoinette Anazodo; Celeste Phillips; Louise Sue; Anthony R Herbert; Jennifer W Mack; Toni Lindsay; Holly Evans; Claire E Wakefield Journal: PLoS One Date: 2022-07-08 Impact factor: 3.752
Authors: Erica C Kaye; Samantha DeMarsh; Courtney A Gushue; Jonathan Jerkins; April Sykes; Zhaohua Lu; Jennifer M Snaman; Lindsay J Blazin; Liza-Marie Johnson; Deena R Levine; R Ray Morrison; Justin N Baker Journal: Oncologist Date: 2018-05-04
Authors: Emily J Labudde; Nicholas P DeGroote; Susie Smith; Jonathan Ebelhar; Kristen E Allen; Sharon M Castellino; Karen Wasilewski-Masker; Katharine E Brock Journal: Cancer Med Date: 2021-03-22 Impact factor: 4.452
Authors: Katharine E Brock; Kristen E Allen; Erin Falk; Cristina Velozzi-Averhoff; Nicholas P DeGroote; Jeffrey Klick; Karen Wasilewski-Masker Journal: Support Care Cancer Date: 2020-08-11 Impact factor: 3.603